EUVIMEDObjevte EUVIMED
Open access

Feasibility of Videoconference-Based Cognitive Behavioral Therapy for Somatic Symptom Disorder: Single-Arm Pilot Trial

Hideki Nakamura iD, Kayoko Taguchi iD, Masayuki Katsushima iD, Sho Okawa iD, Mirai Miyoshi iD, Eiji Shimizu iD

JMIR Formative Research · 2026-05-20 · 10 · e86698-e86698

DOI: 10.2196/86698 ↗

At a glance

Journal article in JMIR Formative Research, published online on 2026-05-20. Written by Hideki Nakamura and 5 co-authors. Institution: Department of Mental Health Nursing, Faculty of Nursing, Toho University, 4-16-20, Omori-Nishi, Ota-ku, Tokyo, 143-0015, Japan, 81 03-3762-9881. Major MEDLINE topics: Cognitive Behavioral Therapy, Videoconferencing, Somatoform Disorders, Medically Unexplained Symptoms. 68 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Somatic symptom disorder (SSD) is a mental disorder marked by persistent somatic symptoms and maladaptive health-related thoughts, feelings, or behaviors. Cognitive behavioral therapy has been shown to be effective in treating SSD, reducing patients’ somatic symptoms, depressive symptoms, and anxiety symptoms. However, challenges remain—including limited access to treatment. Videoconference-based cognitive behavioral therapy (vCBT) has emerged as a promising approach, offering flexible and tailored treatment while addressing the shortage of medical resources and potentially reducing patient dropout.

Objective

This study examined the feasibility of vCBT for patients with SSD and explored secondary outcomes related to the physical component of health-related quality of life (HRQOL) as assessed using the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) physical component summary (PCS) score and other exploratory clinical outcomes.

Methods

This single-arm pilot trial evaluated feasibility as the primary outcome assessed via recruitment rate, retention rate, session completion rate, and safety. Ten participants with SSD were enrolled, and all received 6 weekly 50-minute vCBT sessions. Secondary outcomes included physical HRQOL (SF-36 PCS) as the key secondary outcome, as well as mental HRQOL, depressive symptoms, somatic symptom severity, anxiety symptoms, health anxiety, pain, insomnia, and generic HRQOL. These outcomes were measured at the preintervention (week 0) and postintervention (week 6) time points and 1-month follow-up (week 10) and were analyzed using 2-sided paired t tests.

Results

All feasibility criteria were met, with a recruitment rate of 83.3% (10/12), a retention rate of 100% (10/10), a session completion rate of 100% (10/10), and no adverse events reported. The SF-36 PCS score improved by 4.99 points at the postintervention time point, representing a large within-group effect (Cohen d =0.99, 95% CI 0.21‐1.74). Medium to large improvements were also observed in mental HRQOL, depressive symptoms, anxiety symptoms, health anxiety, pain, insomnia, and generic HRQOL, and most of these improvements were observed at the 1-month follow-up.

Conclusions

Our findings indicate that vCBT is a feasible and safe approach for SSD, with findings suggesting acceptability and preliminary evidence of effectiveness.

Subjects

MeSH terms (MEDLINE)

Cognitive Behavioral TherapyVideoconferencingSomatoform DisordersMedically Unexplained SymptomsHumansPilot ProjectsFemaleFeasibility StudiesMaleMiddle AgedQuality of LifeAdultTreatment OutcomeSurveys and Questionnaires

Author keywords

cognitive behavioral therapyfeasibilityquality of lifesomatic symptom disordertelemedicinevideoconference-based cognitive behavioral therapy

Authors and institutions

  • Department of Mental Health Nursing, Faculty of Nursing, Toho University, 4-16-20, Omori-Nishi, Ota-ku, Tokyo, 143-0015, Japan, 81 03-3762-9881.
  • Research Center for Child Mental Development, Chiba University, Chiba, Japan.
  • Department of Rehabilitation, Faculty of Health Care and Medical Sports, Teikyo Heisei University, Ichihara, Japan.
  • Department of Life Sciences, The University of Tokyo, Tokyo, Japan.
  • Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, Chiba, Japan.

ORCID profiles: Hideki Nakamura, Kayoko Taguchi, Masayuki Katsushima, Sho Okawa, Mirai Miyoshi, Eiji Shimizu

Cite

APA

Nakamura, H., Taguchi, K., Katsushima, M., Okawa, S., Miyoshi, M., & Shimizu, E. (2026). Feasibility of Videoconference-Based Cognitive Behavioral Therapy for Somatic Symptom Disorder: Single-Arm Pilot Trial. JMIR Formative Research, 10, e86698-e86698. https://doi.org/10.2196/86698

Vancouver

Nakamura H, Taguchi K, Katsushima M, Okawa S, Miyoshi M, Shimizu E. Feasibility of Videoconference-Based Cognitive Behavioral Therapy for Somatic Symptom Disorder: Single-Arm Pilot Trial. JMIR Formative Research. 2026;10:e86698-e86698. doi:10.2196/86698

BibTeX
@article{Nakamura2026,
  author = {Nakamura, Hideki and Taguchi, Kayoko and Katsushima, Masayuki and Okawa, Sho and Miyoshi, Mirai and Shimizu, Eiji},
  title = {Feasibility of Videoconference-Based Cognitive Behavioral Therapy for Somatic Symptom Disorder: Single-Arm Pilot Trial},
  journal = {JMIR Formative Research},
  year = {2026},
  volume = {10},
  pages = {e86698--e86698},
  doi = {10.2196/86698}
}
Start for free →